Evidence map›Paper›PMID 37445637›Full record

ArticleInternational journal of molecular sciences2023

LC-MS/MS-Based Serum Metabolomics and Transcriptome Analyses for the Mechanism of Augmented Renal Clearance.

Yidan Wang, Yifan Luo, Shu Yang, Mingyan Jiang, Yang Chu

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Multi-Omics and -Organ Insights into Energy Metabolic Adaptations in Early Sepsis Onset.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yidan WangDepartment of Pharmacy, The First Hospital of China Medical University, Shenyang 110001, China.ORCID 0000-0002-8138-2666
Yifan LuoDepartment of Pharmacy, The First Hospital of China Medical University, Shenyang 110001, China.
Shu YangDepartment of Pharmacy, The First Hospital of China Medical University, Shenyang 110001, China.
Mingyan JiangDepartment of Pharmacy, The First Hospital of China Medical University, Shenyang 110001, China.
Yang ChuDepartment of Pharmacy, The First Hospital of China Medical University, Shenyang 110001, China.
First Hospital of China Medical University · CN

Funding

Natural Science Foundation of Liaoning Province 2020-BS-106
6 · The paper itself

Abstract

Augmented Renal Clearance (ARC) refers to the increased renal clearance of circulating solute in critically ill patients. In this study, the analytical research method of transcriptomics combined with metabolomics was used to study the pathogenesis of ARC at the transcriptional and metabolic levels. In transcriptomics, 534 samples from 5 datasets in the Gene Expression Omnibus database were analyzed and 834 differential genes associated with ARC were obtained. In metabolomics, we used Ultra-Performance Liquid Chromatography-Quadrupole Time-of-Flight Mass Spectrometry to determine the non-targeted metabolites of 102 samples after matching propensity scores, and obtained 45 differential metabolites associated with ARC. The results of the combined analysis showed that purine metabolism, arginine biosynthesis, and arachidonic acid metabolism were changed in patients with ARC. We speculate that the occurrence of ARC may be related to the alteration of renal blood perfusion by LTB4R, ARG1, ALOX5, arginine and prostaglandins E2 through inflammatory response, as well as the effects of

Indexed as

MetabolomicsTandem Mass SpectrometryArginineChromatography, High Pressure LiquidChromatography, LiquidGene Expression ProfilingHumansPhosphofructokinase-2ArgininePFKFB2 protein, humanPhosphofructokinase-2augmented renal clearancemetabolomicstranscriptomevancomycin

Identifiers

PMID37445637
PMCPMC10341629
OpenAlexW4381617747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.